{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:41:59Z","timestamp":1790685719246,"version":"4.1.0"},"reference-count":19,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T00:00:00Z","timestamp":1370304000000},"content-version":"vor","delay-in-days":5878,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Diseases"],"published-print":{"date-parts":[[1997,5]]},"abstract":"<jats:p>OBJECTIVE: Human saliva is known to decrease HIV infectivity <jats:italic>in vitro.<\/jats:italic> The purpose of this study was to extend these findings and to focus on the mechanism of action of these salivary factor(s).<\/jats:p><jats:p>DESIGN: A number of viruses and several assay systems have been utilized to determine if the effect of submandibular saliva is directly on the virus, on the host cell, or on the virus\u2010cell interaction.<\/jats:p><jats:p>MATERIALS AND METHODS: Submandibular saliva from seronegative donors was incubated with HIV\u20101, other retroviruses, or unrelated viruses. Viral infectivity was monitored either by determining p24 antigen levels in peripheral blood mononuclear cells or Sup T1 cells, or using HeLa cells expressing CD4 and an HIV derived long terminal repeat linked to the \u03b2\u2010galactosidase gene.<\/jats:p><jats:p>RESULTS: The inhibition of viral infectivity by submandibular saliva is specific for HIV\u20101. While inhibition increases with time of incubation of saliva with virus, pre\u2010treatment of cells with saliva does not inhibit HIV production, and saliva has only modest inhibitory effects when added to HIV\u2010infected cells.<\/jats:p><jats:p>CONCLUSIONS: It appears that the effect of submandibular saliva on decreasing the infectivity of HIV\u20101 is directly on the virus, rather than on the host cell.<\/jats:p>","DOI":"10.1111\/j.1601-0825.1997.tb00376.x","type":"journal-article","created":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T11:13:24Z","timestamp":1370344404000},"source":"Crossref","is-referenced-by-count":21,"title":["Inhibition of HIV infectivity by human saliva"],"prefix":"10.1111","volume":"3","author":[{"given":"D","family":"Malamud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Nagashunmugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WR","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Kream","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HM","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,6,4]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1990.6.1425"},{"key":"e_1_2_1_3_1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/10454411930040033101","article-title":"Effects of human salivas on recombinant HIV\u20101 proteins","volume":"4","author":"Archibald DW","year":"1993","journal-title":"Crit Rev Oral Biol Med"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/10454411930040033001"},{"key":"e_1_2_1_5_1","first-page":"995","article-title":"Interaction of HIV\u20101 and human salivary mucins","volume":"7","author":"Bergey EJ","year":"1994","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.1988.0002"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.1989.0165"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)92218-X"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(73)90341-3"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.66.4.2232-2239.1992"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1993.9.633"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/10454411930040032901"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118056"},{"key":"e_1_2_1_14_1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1128\/jvi.66.1.235-243.1992","article-title":"Virions of primary human immunodeficiency virus type 1 isolates resistant to sCD4 neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4\u2010sensitive isolates","volume":"66","author":"Moore JP","year":"1992","journal-title":"J Virol"},{"key":"e_1_2_1_15_1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1128\/jvi.69.1.101-109.1995","article-title":"Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomelic gp120","volume":"69","author":"Moore JP","year":"1995","journal-title":"J Virol"},{"key":"e_1_2_1_16_1","unstructured":"NagashunmugamT FriedmanHM SundaresanCet al(1996).Anti\u2010viral activity of human submandibular saliva is specific to HIV\u20101. 3rd Conference on Retroviruses and Opportunistic Infections Washington DC p134."},{"key":"e_1_2_1_17_1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/10454411930040032801","article-title":"Anti\u2010infectivity activity of human salivary secretions toward human immunodeficiency virus","volume":"4","author":"Robinovitch MR","year":"1993","journal-title":"Crit Rev Oral Biol Med"},{"key":"e_1_2_1_18_1","first-page":"310","article-title":"Measurement of salivary inhibition of HIV\u20101 utilizing the MAGI assay","volume":"75","author":"Robinovitch MR","year":"1996","journal-title":"J Dent Res"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/328728a0"},{"key":"e_1_2_1_20_1","first-page":"898","article-title":"Further studies of salivary inhibition of HIV\u20101 infectivity","volume":"5","author":"Yeh CK","year":"1992","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["Oral Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1601-0825.1997.tb00376.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1601-0825.1997.tb00376.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T06:18:09Z","timestamp":1698473889000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1601-0825.1997.tb00376.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,5]]},"references-count":19,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1997,5]]}},"alternative-id":["10.1111\/j.1601-0825.1997.tb00376.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1601-0825.1997.tb00376.x","archive":["Portico"],"relation":{},"ISSN":["1354-523X","1601-0825"],"issn-type":[{"value":"1354-523X","type":"print"},{"value":"1601-0825","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,5]]}}}